These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
42. L-proline-catalysed facile green protocol for the synthesis and antimycobacterial evaluation of [1,4]-thiazines. Indumathi S; Perumal S; Banerjee D; Yogeeswari P; Sriram D Eur J Med Chem; 2009 Dec; 44(12):4978-84. PubMed ID: 19781824 [TBL] [Abstract][Full Text] [Related]
43. Discovery of meta-Amido Bromophenols as New Antitubercular Agents. Liang J; Tang YX; Tang XZ; Liang HJ; Gao Y; Fang C; Zhang TY; Yan M Chem Pharm Bull (Tokyo); 2019 Apr; 67(4):372-381. PubMed ID: 30686792 [TBL] [Abstract][Full Text] [Related]
44. Synthesis, structural, multitargeted molecular docking analysis of anti-cancer, anti-tubercular, DNA interactions of benzotriazole based macrocyclic ligand. Pon Matheswari P; Ilavarasi Jeyamalar J; Iruthayaraj A; Ravindran Durai Nayagam B Bioorg Chem; 2024 Jun; 147():107361. PubMed ID: 38613924 [TBL] [Abstract][Full Text] [Related]
45. Antibacterial activities of sulfonyl or sulfonamide containing heterocyclic derivatives and its structure-activity relationships (SAR) studies: A critical review. Kumar Verma S; Verma R; Xue F; Kumar Thakur P; Girish YR; Rakesh KP Bioorg Chem; 2020 Dec; 105():104400. PubMed ID: 33128966 [TBL] [Abstract][Full Text] [Related]
46. Synthesis of novel pleuromutilin derivatives. Part 1: preliminary studies of antituberculosis activity. Dong YJ; Meng ZH; Mi YQ; Zhang C; Cui ZH; Wang P; Xu ZB Bioorg Med Chem Lett; 2015 Apr; 25(8):1799-1803. PubMed ID: 25736994 [TBL] [Abstract][Full Text] [Related]
47. A rationally designed macrocyclic cavitand that kills bacteria with high efficacy and good selectivity. Choi J; Kim J; Kim K; Yang ST; Kim JI; Jon S Chem Commun (Camb); 2007 Mar; (11):1151-3. PubMed ID: 17347722 [TBL] [Abstract][Full Text] [Related]
48. Synthesis and antibacterial activity of novel 4-chloro-2-mercaptobenzenesulfonamide derivatives. Sławiński J; Żołnowska B; Pirska D; Kędzia A; Kwapisz E J Enzyme Inhib Med Chem; 2013 Feb; 28(1):41-51. PubMed ID: 22145585 [TBL] [Abstract][Full Text] [Related]
49. Pleuromutilin derivatives having a purine ring. Part 1: new compounds with promising antibacterial activity against resistant Gram-positive pathogens. Hirokawa Y; Kinoshita H; Tanaka T; Nakamura T; Fujimoto K; Kashimoto S; Kojima T; Kato S Bioorg Med Chem Lett; 2008 Jun; 18(12):3556-61. PubMed ID: 18511280 [TBL] [Abstract][Full Text] [Related]
50. Synthesis and antitubercular activity of novel amino acid derivatives. Da Costa CF; Pinheiro AC; De Almeida MV; Lourenço MC; De Souza MV Chem Biol Drug Des; 2012 Feb; 79(2):216-22. PubMed ID: 22078007 [TBL] [Abstract][Full Text] [Related]
51. Antimycobacterial activity of 3,4-dichlorophenyl-ureas, N,N-diphenyl-ureas and related derivatives. Scozzafava A; Mastrolorenzo A; Supuran CT J Enzyme Inhib; 2001 Nov; 16(5):425-32. PubMed ID: 11916148 [TBL] [Abstract][Full Text] [Related]
52. Alkylamino derivatives of pyrazinamide: synthesis and antimycobacterial evaluation. Servusová B; Paterová P; Mandíková J; Kubíček V; Kučera R; Kuneš J; Doležal M; Zitko J Bioorg Med Chem Lett; 2014 Jan; 24(2):450-3. PubMed ID: 24388809 [TBL] [Abstract][Full Text] [Related]
53. Synthesis and antimicrobial activity of novel heterocyclic sulfamoyl-phenyl-carboximidamides derived from clinically applied sulfonamides. Gobis K; Foks H; Wiśniewska K; Dąbrowska-Szponar M; Augustynowicz-Kopeć E; Napiórkowska A Arch Pharm (Weinheim); 2012 Nov; 345(11):911-7. PubMed ID: 22886614 [TBL] [Abstract][Full Text] [Related]
54. Synthesis, antimycobacterial screening and ligand-based molecular docking studies on novel pyrrole derivatives bearing pyrazoline, isoxazole and phenyl thiourea moieties. Joshi SD; Dixit SR; Kirankumar MN; Aminabhavi TM; Raju KV; Narayan R; Lherbet C; Yang KS Eur J Med Chem; 2016 Jan; 107():133-52. PubMed ID: 26580979 [TBL] [Abstract][Full Text] [Related]
55. Synthesis and antibacterial activities of some 4,5-dihydro-1H-1,2,4-triazol-5-ones. Yüksek H; Demirbaş A; Ikizler A; Johansson CB; Celik C; Ikizler AA Arzneimittelforschung; 1997 Apr; 47(4):405-9. PubMed ID: 9150862 [TBL] [Abstract][Full Text] [Related]
56. Synthesis and antibacterial activities of novel oxazolidinones having spiro[2,4]heptane moieties. Kim SY; Park HB; Cho JH; Yoo KH; Oh CH Bioorg Med Chem Lett; 2009 May; 19(9):2558-61. PubMed ID: 19345578 [TBL] [Abstract][Full Text] [Related]
57. Synthesis and antibacterial activities of novel oxazolidinones having cyclic sulfonamide moieties. Kim SJ; Jung MH; Yoo KH; Cho JH; Oh CH Bioorg Med Chem Lett; 2008 Nov; 18(21):5815-8. PubMed ID: 18842403 [TBL] [Abstract][Full Text] [Related]
58. Pyridazines 91. Synthesis of substituted tri- and tetracyclic compounds bearing a pyridazine core and their biological evaluation as antimycobacterial agents. Heinisch G; Matuszczak B; Planitzer K Arch Pharm (Weinheim); 2000 Jul; 333(7):231-40. PubMed ID: 10965598 [TBL] [Abstract][Full Text] [Related]
59. Synthesis and antitubercular evaluation of 4-carbonyl piperazine substituted 1,3-benzothiazin-4-one derivatives. Peng CT; Gao C; Wang NY; You XY; Zhang LD; Zhu YX; Xv Y; Zuo WQ; Ran K; Deng HX; Lei Q; Xiao KJ; Yu LT Bioorg Med Chem Lett; 2015 Apr; 25(7):1373-6. PubMed ID: 25754492 [TBL] [Abstract][Full Text] [Related]